Features of the Vaccine:
The vaccine, known as R21/Matrix-M, was developed using US firm Novavax's adjuvant technology. An adjuvant is a substance added to enhance the immune response of a vaccine.
This vaccine has demonstrated effectiveness in various settings, from regions with high seasonal malaria transmission to those with year-round transmission. While the efficacy of three doses declined after a year, a booster shot restored its effectiveness.
One of its significant advantages is its cost, with a price tag of $2-4 per dose, making it comparable to other childhood vaccines and facilitating rapid scale-up a...
Read More...